Manufacturer Theramex says it is expecting resupply of FemSeven (estradiol) and FemSeven Sequi (sequential estradiol/levonorgestrel) patches later in 2021. The shortages of this range relate to an issue with the patch adhesive, which Theramex says it is sourcing from an alternative supplier.
MIMS recently reported that the Elleste HRT range is also now back in stock.
In addition to FemSeven and FemSeven Sequi, the MIMS drug shortages tracker advises that the following HRT preparations remain out of stock with no confirmed date of resupply:
- Bedol (estradiol) tablets
- Clinorette (sequential estradiol/norethisterone) tablets
- Climanor (medroxyprogesterone) tablets
- Ethinylestradiol 10 microgram and 50 microgram tablets
Prescribers can consult the MIMS HRT comparison table to find suitable alternatives.